sequences and interprets genomes to provide diagnoses to people affected by genetic diseases or who have a predisposition to specific genetic conditions. What separates them from the likes of 23andMe and's services is that's goal is to provide information that is meaningful in a clinical sense. At the recent AWS Summit held in Sydney, I spoke with Associate Professor Marcel Dinger, from the Garvan Institute of Medical Research and CEO of, about the evolution of this field and how cloud computing has been an enabler as the company navigates the risks of using cloud systems for such personal data.